Saturn V Capital Management’s Abivax ABVX Stock Holding History

Saturn V Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$60.4M	Sell	542,696 -106,483	-16%	-$12.6M	10.94%	3
2025 Q4	$87.5M	Sell	649,179 -152,045	-19%	-$16.6M	16.07%	1
2025 Q3	$68M	Buy	801,224 +178,745	+29%	+$11M	14.92%	1
2025 Q2	$4.76M	Buy	622,479 +69,553	+13%	+$453K	1.93%	18
2025 Q1	$3.46M	Sell	552,926 -100,145	-15%	-$678K	1.74%	16
2024 Q4	$4.78M	Buy	653,071 +5,052	+0.8%	+$46.5K	1.87%	15
2024 Q3	$7.47M	Buy	648,019 +20,259	+3%	+$243K	2.67%	14
2024 Q2	$8.3M	Buy	627,760 +4,790	+0.8%	+$68.5K	3.14%	14
2024 Q1	$8.91M	Buy	+622,970	New	+$8.03M	3.57%	14

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Saturn V Capital Management's ABVX Position: Q1 2026 in Review

Saturn V Capital Management reduced its Abivax (ABVX) stake by 16% in Q1 2026, selling an estimated $12.6M and leaving 542,696 shares worth $60.4M. The position accounts for 10.94% of the portfolio, ranked #3.

Saturn V Capital Management first reported a position in ABVX in Q1 2024 and has held it in 9 quarters since. The position peaked at $87.5M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

Saturn V Capital Management held 542,696 shares of Abivax worth $60.4M as of Q1 2026.
Saturn V Capital Management sold 106,483 Abivax shares in Q1 2026, an estimated $12.6M.
Abivax made up 10.94% of Saturn V Capital Management's portfolio in Q1 2026, its #3 holding.
Saturn V Capital Management first reported a position in Abivax in Q1 2024 and has held it in 9 quarters since.
Saturn V Capital Management's Abivax position peaked at $87.5M in Q4 2025.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Saturn V Capital Management's 13F filing for Q1 2026, filed 15 May 2026.